Last week, BioNTech and co-developers Pfizer said preliminary analysis showed their vaccine could prevent more than 90 per cent of people from getting Covid-19. Sahin said he was confident the vaccine would reduce transmission between people as well as stop symptoms developing in someone who has had the vaccine. It was possible, he said, the vaccine could halve transmission which would have a big impact. The UK is expected to get 10 million doses of the BioNTech/Pfizer vaccine by the end of the year, with a further 30 million doses already ordered. “The first interim analysis of our global Phase 3 study provides evidence that a vaccine may effectively prevent COVID-19.

Source: Mint November 15, 2020 16:07 UTC